Skip to Content

PLIVA 459 (Theophylline extended-release 300 mg)

Pill with imprint PLIVA 459 is White, Capsule-shape and has been identified as Theophylline extended-release 300 mg. It is supplied by Pliva Inc..

Theophylline is used in the treatment of asthma, maintenance; asthma, acute; apnea of prematurity and belongs to the drug class methylxanthines. Risk cannot be ruled out during pregnancy. Theophylline 300 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for PLIVA 459

Theophylline extended-release 300 mg PLIVA 459
Theophylline extended-release 300 mg PLIVA 459  Front
Theophylline extended-release 300 mg PLIVA 459  Back
Theophylline extended-release 300 mg PLIVA 459

Theophylline extended-release

Imprint:
PLIVA 459
Strength:
300 mg
Color:
White
Size:
14.00 mm
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Methylxanthines
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Pliva Inc.
Inactive Ingredients:
hypromellose 2208 (100 mPa.s)
hypromellose 2208 (100000 mPa.s)
lactose anhydrous
magnesium stearate
povidone
Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide